Advanced search
Publication Cover
Biomarkers Volume 6, 2001 - Issue 6
Submit an article Journal homepage
46
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Assessment of nicotine uptake from cigarette smoke: comparison of a colorimetric test strip (NicCheck I™) and gas chromatography/mass selective detector

H. Thomas Karnes Department of Pharmaceutics, Virginia Commonwealth University, PO Box 980533, Richmond, VA 23298-0533, USA
,
John R. James Department of Pharmaceutics, Virginia Commonwealth University, PO Box 980533, Richmond, VA 23298-0533, USA
,
Clark March Department of Pharmaceutics, Virginia Commonwealth University, PO Box 980533, Richmond, VA 23298-0533, USA
,
Donald E. Leyden PO Box 323, Deltaville, VA 23043, USA
&
Kent Koller Philip Morris USA Research Center, Richmond, VA 23236-6583, USA
Pages 388-399 | Published online: 29 Sep 2008

  • AHIJEVYCH, K. L. and WEWERS, M. E. 1994, Patterns of cigarette consumption and cotinine levels among African American women smokers. American Journal of Respiratory Critical Care Medicine, 150, 1229-1233.
  • AMRUTA, R., ESWARA, A. R., SARASWATHY, V., NOCHUR, P. H. D. and MOSSNTAN, D. J. 1996, Detection of nicotine and its metabolites in urine. American Journal of Health Behavior, 20, 333-345
  • ANDERSON, I. G. M. and PROCTOR, C. J. 1991, Comparison of the measurement of serum cotinine levels by gas chromatography and radioimmunoassay. Analyst, 116, 691.
  • BARLOW, R. D., STONE, R. B., WALD, N. J. and PUHAKAINEN, E. V. J. 1987, The direct barbituric acid assay for nicotine metabolites in urine: a simple colorimetric test for the routine assessment of smoking status and cigarette smoke intake. Clinica Chimica Acta, 165, 45-52.
  • BENDAYAN, R., SULLIVAN, J. T., SHAW, C., FRECKER, R. C. and SELLERS, E. M. 1990, Effect of cimetidine and ranitidine on the hepatic and renal elimination of nicotine in humans. European Journal of Clinical Pharmacology, 38, 165-169.
  • BENOWITZ, N. L. and JACOB, P. 1994, Metabolism of nicotine to cotinine studied by a duel stable isotope method. Clinical Pharmacology and Therapeutics, 56, 483-493.
  • BENOWITZ, N. L., JUYT, F., JACOB, P. L., JONES, R. T. and OSMAN, A. L. 1983, Cotinine disposition and effects. Clinical Pharmacology and Therapeutics, 34, 604-611.
  • BENOWITZ, N. L., JACOB, P., FONG, I. and GUPTA, S. 1994, Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. Journal of Pharmacology and Experimental Therapeutics, 268, 296-303.
  • BJERCKE, R. J., CooK, G., RYCHLIK, N., GJIKA, H. B., VAN VONAKIS, H. and LANGONE, J. J. 1986, Stereospecific monoclonal antibodies to nicotine and cotinine and their use in enzyme-linked immunosorbent assays. Journal of Immunological Methods, 90, 203-213.
  • BJERCKE, R. J., COOK, O. and LANGONE, J. J. 1987, Comparison of monoclonal and polyclonal antibodies to cotinine in nonisotopic and isotopic immunoassays. Journal of Immunological Methods, 96, 239-246.
  • CHANG, K. M., GENTRY, G., DAVIS, R., SITLES, M. and COGGINS, C. R. E. 1992, The 31st Annual Meeting of the Society of Toxicology, Seattle, Washington, USA, February 23-27.
  • CORY-SLECHTA, D. A. and POKORA, M. J. 1995, Lead-induced changes in muscarinic cholinergic sensitivity. Neurotoxicology, 16, 337-347.
  • DAMAJ, M. I., PATRICK, G. S., CREASY, K. R. and MARTIN, B. R. 1997, Pharmacology of lobeline, a nicotinic receptor ligand. Journal of Pharmacology and Experimental Therapeutics, 282, 409-410.
  • DAVIS, R. A., STILES, M. F., DEBETHIZY, J. D. and REYNOLDS, J. H. 1991, Dietary nicotine: a source of urinary corinine. Food Chemistry and Toxicology 29, 821-827.
  • DOMINO, E. F. 1995, Nontobacco sources of cotinine in the urine of nonsmokers. Clinical Pharmacology and Therapeutics, 57, 479.
  • DOMINO, E. F., HORNBACK, H. and DEMANA, T. 1993, The nicotine content of common vegetables. New England Journal of Medicine, 329, 1581.
  • ESWARA, A. R., NOCHUR, S. V. and MOSSMAN, D. J. 1996, Detection of nicotine and its metabolites in urine. American Journal of Health Behavior, 20, 333.
  • FRIESEN, M. D., CUMMINGS, D. A., GARREN, L., BUTLER, R., BARTSCH, H. and SCHUT, H. 1996, Validation in rats of two biomarkers of exposure to the food-borne carcinogen 2-amino-lmethyl-6-phenylimidazo[4,5-b]pyridine(PhIP): PhIP-DNA adducts and urinary PhIP. Carcinogenesis, 17, 67-72.
  • HEE, J., CALLAIS, F., MOMAS, I., LACRENT, A. M., MIN, S., MOLINIER, P., CHASTAGNIER, M., CLAUDE, J. R. and FESTY, B. 1995, Smoker's behaviour and exposure according to cigarette yield and smoking experience. Pharmacology, Biochemistry, and Behavior, 52, 195-203.
  • HORTSMAN, M. 1985, Simple high-performance liquid Chromatographie method for rapid determination of nicotine and cotinine in urine. Journal of Chromatrography, 344, 391-396.
  • JACOB, P., WILSON, M. and BENOWITZ, N. L. 1981, Improved gas Chromatographie method for the determination of nicotine and cotinine in biologic fluids. Journal of Chromatography, 222, 61-70
  • JACOB, P. Ill, YU, L., WILSON, M. and BENOWITZ, N. L. 1991, Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans. Biological Mass Spectrometry, 20, 247-252.
  • JACOB, P. Ill, YU, L., SHULGIN, A. T. and BENOWITZ, N. L. 1999, Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. American Journal of Public Health, 89, 731-736.
  • JARVIS, M. J., STRACHAN, D. P. and FEYERABEND, C. 1992, Determinants of passive smoking in children in Edinburgh, Scotland. American Journal of Public Health, 82, 1225-1229.
  • KNIGHT·, G. J., WYLIE, P., HOLMAN, M. S. and HADDOW, J. E. 1985, Improved 125I radioimmunoassay for cotinine by selective removal of bridge antibodies. Clinical Chemistry, 31, 118-121.
  • KYEREMATEN, G. A., MORGAN, M. L., CHATTOPADHYAY, B., DEBETHIZY, J. D. and VESELL, E. S. 1990, Disposition of nicotine and eight metabolites in smokers and nonsmokers: identification in smokers of two metabolites that are longer lived than cotinine. Clinical Pharmacology and Therapeutics, 48, 641-651.
  • LANGONE, J. J., GJIKA, H. B. and VAN VUNAKIS, H. 1973, Nicotine and its metabolites: radioimmunoassays for nicotine and cotinine. Biochemistry, 12, 5025-5030.
  • LEQUANG, N. T., MIGCERES, M. L., ROCHE, D., ROUSSEL, G., MAHUZIER, G., CHRETIEN, J. and EKINDJIAM, O. G. 1989, Elimination of caffeine interference in HPLC determination of urinary nicotine and cotinine. Clinical Chemistry, 35, 1456-1459.
  • LUNELL, E., BERGSTROM, M., ANTONI, G., LANGSTROM, B. and NORDBERG, A. 1996, Nicotine deposition and body distribution from a nicotine inhaler and a cigarette studied with positron emission tomography. Clinical Pharmacology and Therapeutics, 59, 593-594.
  • MOFFAT, A. C., JACKSON, J. V., Moss, M. S. and WIDDOP, B. (editors) 1986, Clarke's Isolation and Identification of Drugs (London: The Pharmaceutical Press).
  • PEACH, H., ELLARD, G. A., JENNER, P. J. and MORRIS, R. W. 1985, A simple, inexpensive urine test of smoking. Thorax, 40, 351-357.
  • SAKAMOTO, K. and NAKAMURA, Y. 1994, Stereoselective disposition and metabolism of pinacidil in a rat. Xenobiotica, 24, 329-338.
  • SCHEPERS, G. and WALK, R. A. 1988, Cotinine determination by immunoassays may be influenced by other nicotine metabolites. Archives of Toxicology, 62, 395-397.
  • THOMAS, B. H., WHITEHOUSE, L. W., SOLOMONRAY, G. and PAUL, C. J. 1990, Excretion of phenazopyridine and its metabolites in the urine of humans, rats, mice, and guinea pigs. Journal of Pharmaceutical Sciences, 79, 321-325.
  • VEREBEY, K. G., DEFACE, A. and MULE, S. J. 1982, A rapid, quantitative GLC method for the simultaneous determination of nicotine and cotinine. Journal of Analytical Toxicology, 6, 294296.
  • WEAVER, V. M., DAVOLI, C. T., MURPHY, S. E., SUNYER, J., HELLER, J., COLOSIMO, S. G. and GROOPMAN, J. D. 1996, Environmental tobacco smoke exposure in inner-city children. Cancer Epidemiology, Biomarkers and Prevention, 5, 135-137.
  • United States Pharmacupia Convention, INC. Rockville, MD, 1997, Drug Information for the Health Care Professional, 17th edition (USP DI).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.